» Articles » PMID: 37761391

The Current Role of the SFlt-1/PlGF Ratio and the Uterine-Umbilical-Cerebral Doppler Ultrasound in Predicting and Monitoring Hypertensive Disorders of Pregnancy: An Update with a Review of the Literature

Overview
Specialty Health Services
Date 2023 Sep 28
PMID 37761391
Authors
Affiliations
Soon will be listed here.
Abstract

Regarding the hypertensive disorders of pregnancy, pre-eclampsia (PE) remains one of the leading causes of severe and life-threatening maternal and fetal complications. Screening of early-onset PE (<34 weeks of pregnancy), as well as late-onset PE (≥34 weeks), shows poor performance if based solely on clinical features. In recent years, biochemical markers from maternal blood-the pro-angiogenic protein placental growth factor (PlGF) and the antiangiogenic protein soluble FMS-like tyrosine kinase 1 (sFlt-1)-and Doppler velocimetry indices-primarily the mean uterine pulsatility index (PI), but also the uterine resistivity index (RI), the uterine systolic/diastolic ratio (S/D), uterine and umbilical peak systolic velocity (PSV), end-diastolic velocity (EDV), and uterine notching-have all shown improved screening performance. In this review, we summarize the current status of knowledge regarding the role of biochemical markers and Doppler velocimetry indices in early prediction of the onset and severity of PE and other placenta-related disorders, as well as their role in monitoring established PE and facilitating improved obstetrical surveillance of patients categorized as high-risk in order to prevent adverse outcomes. A sFlt-1/PlGF ratio ≤ 33 ruled out early-onset PE with 95% sensitivity and 94% specificity, whereas a sFlt-1/PlGF ≥88 predicted early-onset PE with 88.0% sensitivity and 99.5% specificity. Concerning the condition's late-onset form, sFlt-1/PlGF ≤ 33 displayed 89.6% sensitivity and 73.1% specificity in ruling out the condition, whereas sFlt-1/PlGF ≥ 110 predicted the condition with 58.2% sensitivity and 95.5% specificity. The cut-off values of the sFlt-1/PlGF ratio for the screening of PE were established in the PROGNOSIS study: a sFlt-1/PlGF ratio equal to or lower than 38 ruled out the onset of PE within one week, regardless of the pregnancy's gestational age. The negative predictive value in this study was 99.3%. In addition, sFlt-1/PlGF > 38 showed 66.2% sensitivity and 83.1% specificity in predicting the occurrence of PE within 4 weeks. Furthermore, 2018 ISUOG Practice Guidelines stated that a second-trimester mean uterine artery PI ≥ 1.44 increases the risk of later PE development. The implementation of a standard screening procedure based on the sFlt-1/PlGF ratio and uterine Doppler velocimetry may improve early detection of pre-eclampsia and other placenta-related disorders.

Citing Articles

The predictive value of placental growth factor combined with uterine ultrasound arterial blood flow characteristics for preeclampsia.

Xiao F, Li C, Wang X, Li J Pak J Med Sci. 2025; 41(2):426-431.

PMID: 39926686 PMC: 11803773. DOI: 10.12669/pjms.41.2.11349.


Endothelial METAP1: Tipping the Angiogenic Scales in Postpartum Preeclampsia.

Faulkner J, Alexander M Circ Res. 2025; 136(2):191-193.

PMID: 39819019 PMC: 11750174. DOI: 10.1161/CIRCRESAHA.124.325503.


A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at....

Chirila C, Marginean C, Ghiga D, Voidazan S, Chirila P, Gliga M Children (Basel). 2024; 11(4).

PMID: 38671685 PMC: 11049313. DOI: 10.3390/children11040468.

References
1.
Prakansamut N, Phupong V . Serum SHARP1 and uterine artery Doppler for the prediction of preeclampsia. Sci Rep. 2019; 9(1):12266. PMC: 6706446. DOI: 10.1038/s41598-019-48727-8. View

2.
Cerdeira A, OSullivan J, Ohuma E, James T, Papageorghiou A, Knight M . Performance of soluble fms-like tyrosine kinase-1-to-placental growth factor ratio of ≥85 for ruling in preeclampsia within 4 weeks. Am J Obstet Gynecol. 2020; 224(3):322-323. DOI: 10.1016/j.ajog.2020.11.007. View

3.
Ciciu E, Paatu-Cornea A, Dumitru S, Petcu L, Salim C, Tuta L . Utility of sFtl-1 and Placental Growth Factor Ratio for Adequate Preeclampsia Management. Healthcare (Basel). 2023; 11(3). PMC: 9914058. DOI: 10.3390/healthcare11030381. View

4.
Caillon H, Tardif C, Dumontet E, Winer N, Masson D . Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center. Ann Lab Med. 2017; 38(2):95-101. PMC: 5736685. DOI: 10.3343/alm.2018.38.2.95. View

5.
Cavoretto P, Salmeri N, Candiani M, Farina A . Reference ranges of uterine artery pulsatility index from first to third trimester based on serial Doppler measurements: longitudinal cohort study. Ultrasound Obstet Gynecol. 2022; 61(4):474-480. DOI: 10.1002/uog.26092. View